Korean Cannabinoid Association to Test Cannabidiol Using Blockchain

The Korean Cannabinoid Association plans to use blockchain technology to carry out some studies on cannabidiol. The Korean Cannabinoid Association (KCA) announced during a conference last week in Seoul that it will begin clinical studies on cannabidiol (CBD), a constituent drug of cannabis used in chronic neurological disease therapies such as multiple sclerosis. The project …